Assessing the influence of actinic keratosis on patients' quality of life: the AKQoL questionnaire.
about
Methods and Results Report - Evidence and consensus-based (S3) Guidelines for the Treatment of Actinic Keratosis -International League of Dermatological Societies in cooperation with the European Dermatology Forum.Health related quality of life in patients with actinic keratosis--an observational study of patients treated in dermatology specialist care in Denmark.Tumor-Preferential Induction of Immune Responses and Epidermal Cell Death in Actinic Keratoses by Ingenol Mebutate.Improved patient satisfaction using ingenol mebutate gel 0.015% for the treatment of facial actinic keratoses: a prospective pilot study.Patient-reported outcomes in topical field treatment of actinic keratosis in Swedish and Danish patients.Spanish version of the Actinic Keratosis Quality of Life questionnaire.Patient satisfaction and reported outcomes on the management of actinic keratosis.Quality of life in treatment of AK: Treatment burden of ingenol mebutate gel is small and short lasting.A Spanish version of the Skin Cancer Index: a questionnaire for measuring quality of life in patients with cervicofacial nonmelanoma skin cancer.British Association of Dermatologists' guidelines for the care of patients with actinic keratosis 2017.Three-Day Field Treatment with Ingenol Disoxate (LEO 43204) for Actinic Keratosis: Cosmetic Outcomes and Patient Satisfaction from a Phase II Trial.Patient-reported health outcomes in patients with non-melanoma skin cancer and actinic keratosis: results from a large-scale observational study analysing effects of diagnoses and disease progression.Real-world approach to actinic keratosis management: practical treatment algorithm for office-based dermatology.
P2860
Q35767304-ECC221C3-EF43-4D8A-B123-E3C7E1E56E5FQ35899890-DF0AF85D-645E-4AA5-8CEE-0495584971CAQ36128569-A134EE08-4236-4298-A6D0-D5593F5E5371Q36838300-71CCBB5D-0C61-4C50-92BC-97151853B026Q38704132-16D3EC67-B683-4FB7-A47D-4671D2A50466Q39009634-8E630741-AAD3-4CA2-8AE1-C2AE0C520D36Q39335529-0461223E-C9B4-4881-9A0A-66ED0BD0BAE8Q40814508-A7627501-D1D3-4D7B-A71B-D8F7F72FC0DBQ42460297-94F65465-E0D2-481B-B6E4-42CDEF61284EQ48063272-13C7D83B-52F2-483D-A9E3-8992C81BC8AAQ49178062-CDC0E429-154D-4FB9-9F3A-88312493966BQ49907978-8176FF1E-EC60-4DB4-BBD8-21F84A4EA863Q50225349-D097DEDF-A220-47C3-A5D0-25712823185E
P2860
Assessing the influence of actinic keratosis on patients' quality of life: the AKQoL questionnaire.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Assessing the influence of act ...... life: the AKQoL questionnaire.
@en
type
label
Assessing the influence of act ...... life: the AKQoL questionnaire.
@en
prefLabel
Assessing the influence of act ...... life: the AKQoL questionnaire.
@en
P2860
P356
P1476
Assessing the influence of act ...... life: the AKQoL questionnaire
@en
P2093
P2860
P304
P356
10.1111/BJD.12036
P407
P577
2013-02-01T00:00:00Z